.webp)
.webp)
Discover
.svg){kind=icon}
The Fertility Billing & Payment Modernization Playbook
Ten parts on why fertility billing breaks where it does and what modern payment infrastructure fixes. For clinics and the networks consolidating them.
Fertility care pairs the most advanced clinical technology in medicine with some of the most punishing billing in healthcare. A single IVF cycle runs $15,000 to $30,000. Twenty-five states and Washington, D.C. mandate some form of fertility coverage, though only 15 states and D.C. require IVF specifically, and self-funded employer plans are exempt from all of them. Patients arrive self-pay, financially exposed, and emotionally stretched.
This ten-part series is written for practice administrators, revenue cycle leaders, and the executives running consolidated fertility networks. It covers:
- Why patients are still surprised by the bill, and what transparency actually requires
- Coordinating benefits across medical, pharmacy, and employer fertility carve-outs
- Cycle-based care and why visit-based billing cannot represent it
- Shared-risk programs, embryo storage fees, and the revenue hiding in both
- Why patients walk away from treatment for financial reasons more often than clinical ones
- What private equity consolidation demands from collections and reporting
- Egg freezing and the younger, more price-conscious patient it brings through the door
The argument underneath all ten parts is simple: clinical outcomes between clinics are increasingly comparable, and the financial experience is one of the few differentiators left. When you are ready to act on it, see how PatientPay supports fertility clinics.
Fertility treatment is one of the largest out-of-pocket medical purchases most patients will ever make. Only 15 states and Washington, D.C. require insurers to cover IVF, and self-funded employer plans are exempt from those mandates. The price quoted at consultation and the bill that arrives weeks later are almost never the same number, and the gap between them is quietly shaping which fertility groups are winning patient trust in 2026.
Nearly half of large U.S. employers now offer fertility benefits, often through a specialized vendor that pays a defined portion of the cycle and leaves the patient responsible for the rest. The arrangement is good for patients, but for fertility groups, it has quietly created one of the most complicated coordination-of-benefits puzzles in modern healthcare.
Cryopreservation and storage are some of the most predictable revenue a fertility group will ever generate, and some of the most consistently uncollected. The cause is not patient unwillingness to pay. It's a billing experience that loses contact with the patient at exactly the moment recurring revenue starts.
Shared-risk and multi-cycle programs have become a defining feature of premium fertility care, and patients increasingly expect them. The clinical and pricing logic is well-understood, but the billing infrastructure required to actually run these programs cleanly is where many groups quietly struggle.
In a little over a decade, fertility care has gone from a market of independent groups to one dominated by sophisticated, multi-site networks backed by institutional capital. The expectations these networks bring to billing infrastructure are reshaping what every fertility group, regardless of ownership, needs to be able to deliver.
Egg freezing volume has grown more than 500% in a decade and 39% in the most recent reporting year alone, almost entirely paid out of pocket by patients who don't fit the traditional IVF profile. The clinics that recognize this is a different business with different billing requirements are positioned to dominate the next decade of fertility growth.
Get Started with PatientPay Today
Simplify payments, reduce costs, and enhance patient satisfaction with a modern billing experience—seamless, secure, and built for your practice.
